Researcher
Isabelle Vanden Bempt
- Disciplines:Clinical genetics and molecular diagnostics, Medical genomics, Medical transcriptomics
Affiliations
- Laboratory for Genetics of Malignant Disorders (Division)
Member
From24 Nov 2021 → Today - Department of Human Genetics (Department)
Member
From1 Oct 2018 → 23 Nov 2021 - Translational Cell & Tissue Research (Division)
Member
From15 Aug 2003 → 30 Sep 2008
Projects
1 - 5 of 5
- Whole transcriptome sequencing for lung adenocarcinoma diagnosisFrom1 Feb 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optical genome mapping for comprehensive genetic analysis of sarcomas in a diagnostic setting.From1 Jan 2023 → TodayFunding: FWO Humanitarian research project Stand up against Cancer
- Whole-genome optical mapping for comprehensive analysis of sarcoma genomes in a diagnostic settingFrom13 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Genomic Medicine: Translation of Whole Genome Analyses to Health GenomicsFrom1 May 2018 → TodayFunding: IOF - mandates, IOF - Industrial Research Fund
- Towards a better selection of systemic treatment for patients with ER-positive HER2-negative breast cancer: the use of prognostic and predictive markers in early and metastatic settingFrom1 May 2017 → 14 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
11 - 20 of 46
- Towards a better selection of systemic treatment for patients with ER-positive HER2-negative breast cancer: the use of prognostic and predictive markers in early and metastatic setting(2021)
Authors: Laurence Slembrouck, Patrick Neven, Isabelle Vanden Bempt, Beppe Floris
- Comprehensive immunomolecular profiling of endometrial carcinoma: A tertiary retrospective study(2021)
Authors: Sara Vander Borght, Lien Spans, Hilde Brems, Annouschka Laenen, Ignace Vergote, Toon Van Gorp, Els Van Nieuwenhuysen, Sileny Han, Stefan Timmerman, Anne-Sophie Van Rompuy, et al.
Pages: 694 - 701 - Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma(2021)
Authors: Michael Dewaele, Panagiotis Karras, Nina Van Raemdonck, Dennis Pedri, Jonas Demeulemeester, Sara Vander Borght, Francesca Bosisio, Joost van den Oord, Isabelle Vanden Bempt, Diether Lambrechts, et al.
Pages: 1135 - + - Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2-early breast cancer(2021)
Authors: Laurence Slembrouck, Isabelle Vanden Bempt, Hans Wildiers, Ann Smeets, Anne-Sophie Van Rompuy, Chantal Van Ongeval, Caroline Weltens, Kevin Punie, Els Van Nieuwenhuysen, Sileny Han, et al.
Pages: 1297 - 1309 - Curative, Organ-Sparing, Multimodal, Perioperative Treatment of a Young Patient with a Rectoanal Inflammatory Myofibroblastic Tumor(2021)
Authors: Patrick Schöffski, Sara Vander Borght, Isabelle Vanden Bempt, Vincent Vandecaveye, Raf Sciot, Gert De Hertogh, Albert Wolthuis
Pages: 269 - 275 - Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies(2021)
Authors: Liesbeth Lenaerts, Nathalie Brison, Charlotte Maggen, Huiwen Che, Peter Vandenberghe, Daan Dierickx, Lucienne Michaux, Barbara Dewaele, Patrick Neven, Beppe Floris, et al.
- Comprehensive targeted next-generation sequencing approach in the molecular diagnosis of gastrointestinal stromal tumor(2021)
Authors: Isabelle Vanden Bempt, Sara Vander Borght, Raf Sciot, Lien Spans, Hilde Brems, Baki Topal, Patrick Schöffski, Eric Legius, Maria Debiec-Rychter
Pages: 239 - 249 - An Unexpected Response to Imatinib in a "Wild-Type" Gastrointestinal Stromal Tumor(2020)
Authors: Sara Vander Borght, Isabelle Vanden Bempt, Patrick Schöffski
Pages: 470 - 473 - Rhabdomyosarcoma of the Adult Prostate: Two Cases With Molecular and Cytogenetic Analyses(2020)
Authors: Iryna Samarska, Mari CM van den Hout, Xiaofei Li, Joep GH van Roermund, Tom AT Marcelissen, Isabelle Vanden Bempt, Raf Sciot, Axel zur Hausen
Pages: 133 - 137 - Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D(2020)
Authors: Stefan Timmerman, Anne-Sophie Van Rompuy, Toon Van Gorp, Isabelle Vanden Bempt, Hilde Brems, Els Van Nieuwenhuysen, Sileny Han, Patrick Neven, Annouschka Laenen, Ignace Vergote
Pages: 245 - 251